Search research articles
Contact Us
Filters
Showing results (41-50 of 56) with videos related to
Page
of 6
Sort By:
Clinical Lung Cancer
|
February 25, 2020
Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients
Ravi Rajaram, Arlene M Correa, Ting Xu, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 30, 2021
Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document
Arjun Pennathur, Alessandro Brunelli, Gerard J Criner, et al.
Targeted Oncology
|
December 9, 2017
Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial
Kazuto Harada, Xuemei Wang, Yusuke Shimodaira, et al.
Annals of Surgical Oncology
|
October 7, 2025
Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-Surg
Paula Marincola Smith, Koichi Tomita, Samuel Cass, et al.
Seminars in Thoracic and Cardiovascular Surgery
|
December 11, 2024
Systematic Review of Image-Guided Thermal Ablation for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer
Michael Lanuti, Robert D Suh, Gerard J Criner, et al.
Seminars in Thoracic and Cardiovascular Surgery
|
December 11, 2024
Treatment Selection for the High-Risk Patient with Stage I Non-Small Cell Lung Cancer: Sublobar Resection, Stereotactic Ablative Radiotherapy or Image-Guided Thermal Ablation?
Arjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Seminars in Thoracic and Cardiovascular Surgery
|
December 14, 2024
Systematic Review of Stereotactic Ablative Radiotherapy (SABR)/Stereotactic Body Radiation Therapy (SBRT) for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer
Andrea Wolf, Billy W Loo, Raymond H Mak, et al.
Seminars in Thoracic and Cardiovascular Surgery
|
December 13, 2024
Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer
Arjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Seminars in Thoracic and Cardiovascular Surgery
|
December 15, 2024
Systematic Review of the Comparative Studies of Image-Guided Thermal Ablation, Stereotactic Radiosurgery, and Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer
Arjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
British Journal of Cancer
|
December 14, 2017
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
Yusuke Shimodaira, Rebecca S Slack, Kazuto Harada, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 56) with videos related to
Sort By:
Page
of 6
Clinical Lung Cancer
|
February 25, 2020
Locoregional Control, Overall Survival, and Disease-Free Survival in Stage IIIA (N2) Non-Small-Cell Lung Cancer: Analysis of Resected and Unresected Patients
Ravi Rajaram, Arlene M Correa, Ting Xu, et al.
The Journal of Thoracic and Cardiovascular Surgery
|
October 30, 2021
Definition and assessment of high risk in patients considered for lobectomy for stage I non-small cell lung cancer: The American Association for Thoracic Surgery expert panel consensus document
Arjun Pennathur, Alessandro Brunelli, Gerard J Criner, et al.
Targeted Oncology
|
December 9, 2017
Early Metabolic Change after Induction Chemotherapy Predicts Histologic Response and Prognosis in Patients with Esophageal Cancer: Secondary Analysis of a Randomized Trial
Kazuto Harada, Xuemei Wang, Yusuke Shimodaira, et al.
Annals of Surgical Oncology
|
October 7, 2025
Psychometric Validation of a new module of MD Anderson Symptom Inventory (MDASI) for Patients with Upper Gastrointestinal Cancers: MDASI-UGI-Surg
Paula Marincola Smith, Koichi Tomita, Samuel Cass, et al.
Seminars in Thoracic and Cardiovascular Surgery
|
December 11, 2024
Systematic Review of Image-Guided Thermal Ablation for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer
Michael Lanuti, Robert D Suh, Gerard J Criner, et al.
Seminars in Thoracic and Cardiovascular Surgery
|
December 11, 2024
Treatment Selection for the High-Risk Patient with Stage I Non-Small Cell Lung Cancer: Sublobar Resection, Stereotactic Ablative Radiotherapy or Image-Guided Thermal Ablation?
Arjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Seminars in Thoracic and Cardiovascular Surgery
|
December 14, 2024
Systematic Review of Stereotactic Ablative Radiotherapy (SABR)/Stereotactic Body Radiation Therapy (SBRT) for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer
Andrea Wolf, Billy W Loo, Raymond H Mak, et al.
Seminars in Thoracic and Cardiovascular Surgery
|
December 13, 2024
Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer
Arjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
Seminars in Thoracic and Cardiovascular Surgery
|
December 15, 2024
Systematic Review of the Comparative Studies of Image-Guided Thermal Ablation, Stereotactic Radiosurgery, and Sublobar Resection for Treatment of High-Risk Patients with Stage I Non-Small Cell Lung Cancer
Arjun Pennathur, Michael Lanuti, Robert E Merritt, et al.
British Journal of Cancer
|
December 14, 2017
Influence of induction chemotherapy in trimodality therapy-eligible oesophageal cancer patients: secondary analysis of a randomised trial
Yusuke Shimodaira, Rebecca S Slack, Kazuto Harada, et al.
Page
of 6